Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls

References

• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseGlobal Initiative for Chronic Obstructive Lung Disease Available from: http://www.goldcopd.com/uploads/users/files/GOLD_Report_2014_Oct30.pdfAccessed December 15, 2014
   Google Scholar
• Japanese Respiratory SocietyGuidelines for the Diagnosis and Treatment of COPD4th editionJapanese Respiratory Society2013 Available from: https://www.jrs.or.jp/modules/guidelines/index.php?content_id=1Accessed April 19, 2013
   Google Scholar
• FukuchiYNishimuraMIchinoseMCOPD in Japan: the Nippon COPD Epidemiology studyRespirology20049445846515612956
   PubMed Web of Science ®Google Scholar
• BarnesPJMediators of chronic obstructive pulmonary diseasePharmacol Rev200456451554815602009
   PubMed Web of Science ®Google Scholar
• HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med2004350262645265315215480
   PubMed Web of Science ®Google Scholar
• MacNeeWSystemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary diseaseAnn Med201345329130023110517
   PubMed Web of Science ®Google Scholar
• HuertasAPalangePCOPD: a multifactorial systemic diseaseTher Adv Respir Dis20115321722421429981
   PubMedGoogle Scholar
• AgustíASystemic effects of chronic obstructive pulmonary disease: what we know and what we don’t know (but should)Proc Am Thorac Soc20074752252517878464
   PubMedGoogle Scholar
• van EedenSFSinDDChronic obstructive pulmonary disease: a chronic systemic inflammatory diseaseRespiration200875222423818042978
   PubMed Web of Science ®Google Scholar
• WedzichaJASeemungalTACOPD exacerbations: defining their cause and preventionLancet2007370958978679617765528
   PubMed Web of Science ®Google Scholar
• FujimotoKYasuoMUrushibataKHanaokaMKoizumiTKuboKAirway inflammation during stable and acutely exacerbated chronic obstructive pulmonary diseaseEur Respir J200525464064615802337
   PubMed Web of Science ®Google Scholar
• BarnesNCQiuY-SPavordIDSCO30005 Study GroupAntiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung diseaseAm J Respir Crit Care Med2006173773674316424444
   PubMed Web of Science ®Google Scholar
• LomasDASilvermanEKEdwardsLDMillerBECoxsonHORTal-SingerREvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigatorsEvaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohortThorax200863121058106318757456
   PubMed Web of Science ®Google Scholar
• VestboJEdwardsLDScanlonPDECLIPSE InvestigatorsChanges in forced expiratory volume in 1 second over time in COPDN Engl J Med2011365131184119221991892
   PubMed Web of Science ®Google Scholar
• DickensJAMillerBEEdwardsLDSilvermanEKLomasDATal-SingerREvaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) study investigatorsCOPD association and repeatability of blood biomarkers in the ECLIPSE cohortRespir Res201112114615522054035
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVATS/ERS Task ForceStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• SugiyamaAHattoriNHarutaYCharacteristics of inspiratory and expiratory reactance in interstitial lung diseaseRespir Med2013107687588223582576
   PubMed Web of Science ®Google Scholar
• NakagawaMHattoriNHarutaYEffect of increasing respiratory rate on airway resistance and reactance in COPD patientsRespirology Epub2014923
   Web of Science ®Google Scholar
• IshikawaNHattoriNTanakaSLevels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysisRespiration2011821101821474912
   PubMed Web of Science ®Google Scholar
• PaggiaroPLChanezPHolzOSputum inductionEur Respir J Suppl2002373s8s12361361
   PubMedGoogle Scholar
• BarnesNReducing inflammation in COPD: the evidence buildsThorax2007621192792817965073
   PubMed Web of Science ®Google Scholar
• AgustiACalverleyPMACelliBEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigatorsCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res201011112213520831787
   PubMed Web of Science ®Google Scholar
• StănescuDSannaAVeriterCAirways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophilsThorax19965132672718779129
   PubMed Web of Science ®Google Scholar
• ToungoussovaOMiglioriGBFoschino BarbaroMPChanges in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary diseaseRespir Med200710171543154817258444
   PubMed Web of Science ®Google Scholar
• IwamotoHGaoJKoskelaJDifferences in plasma and sputum biomarkers between COPD and COPD-asthma overlapEur Respir J201443242142923794464
   PubMed Web of Science ®Google Scholar
• MakrisDVrekoussisTIzoldiMIncreased apoptosis of neutrophils in induced sputum of COPD patientsRespir Med200910381130113519329291
   PubMed Web of Science ®Google Scholar
• BazzoniFCassatellaMARossiFCeskaMDewaldBBaggioliniMPhagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8J Exp Med199117337717741997655
   PubMed Web of Science ®Google Scholar
• Pinto-PlataVMMüllerovaHTosoJFC-reactive protein in patients with COPD, control smokers and non-smokersThorax200611232816143583
   PubMed Web of Science ®Google Scholar
• van DurmeYMVerhammeKMAarnoudseAJC-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009179537538219096002
   PubMed Web of Science ®Google Scholar
• IshikawaNHattoriNYokoyamaAKohnoNUtility of KL-6/MUC1 in the clinical management of interstitial lung diseasesRespir Investig2012501313
   PubMedGoogle Scholar
• BizetoLMazzoliniABRibeiroMStelmachRCukierANunesMPTInterrelationship between serum and sputum inflammatory mediators in chronic obstructive pulmonary diseaseBraz J Med Biol Res200841319319818327434
   PubMed Web of Science ®Google Scholar
• RöpckeSHolzOLauerGRepeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputumPLoS ONE2012710e4620723056262
   PubMed Web of Science ®Google Scholar
• DuvoixADickensJHaqIBlood fibrinogen as a biomarker of chronic obstructive pulmonary diseaseThorax201368767067622744884
   PubMed Web of Science ®Google Scholar